Amgen at Antibody Engineering 2026

Dec 13–16, 2026 San Diego, CA ~900 attendees Website

Amgen takes part in 4 sessions at Antibody Engineering 2026 in San Diego. Its program centers on what matters most when taking an antibody from discovery to a first clinical trial filing, and on antibodies that work by induced proximity. It also covers generative AI protein design that is steered toward molecules that are easy to develop and manufacture.

OrganizationAntibody Engineering 2026 Attendance
Amgen
Thousand Oaks, CA
Large pharma
Global biopharmaceutical company developing and manufacturing biologic medicines, including bispecific T-cell engagers.
Chair
Sun Dec 13
1:00pm–1:15pm
Co-Chairs' Remarks: From Discovery to IND: What Matters Most and How to Get it Right
Workshop 1: From Discovery to IND: What Matters Most and How to Get it Right · with Xencor
Talk
Sun Dec 13
1:15pm–1:45pm
Developability-Guided Generative Biology for Therapeutic Protein Engineering
Designing new therapeutic proteins by computer while checking from the start that they can be made and purified.
AI & computational design
Talk
Sun Dec 13
4:15pm–5:00pm
Moderated Panel Discussion with Session Speakers
Workshop 1: From Discovery to IND: What Matters Most and How to Get it Right · with Xencor
Talk
Mon Dec 14
5:45pm–6:15pm
Induced Proximity and Next-Generation Antibody Therapeutics
Track 2: Engineering Solutions for Accessing Difficult Targets
Bispecifics & multispecifics

Explore the full Antibody Engineering 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full Antibody Engineering 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Amgen

Tell us what you sell and we’ll find the people at Amgen most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by Antibody Engineering & Therapeutics, its organizers or The Antibody Society. Submit a correction